Tirzepatide 10mg Bulk Powder - High Purity GLP-1/GIP Dual Agonist for Research

Tirzepatide 10mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This innovative peptide demonstrates significant potential in metabolic disorder research, particularly for type 2 diabetes and weight management studies.

The tirzepatide 10mg formulation appears as a white lyophilized powder with 99% purity. As a synthetic peptide, it mimics the effects of natural incretin hormones while offering enhanced stability and prolonged activity. Researchers have observed its ability to stimulate insulin secretion, suppress glucagon release, and delay gastric emptying.

In clinical research settings, tirzepatide 10mg has shown remarkable efficacy in glycemic control and weight reduction. Studies indicate it may produce superior results compared to single GLP-1 receptor agonists, with weight loss effects comparable to bariatric surgery in some cases. The compound's unique mechanism combines the benefits of both GIP and GLP-1 pathways.

Key research applications for tirzepatide 10mg include:
- Blood glucose regulation studies
- Obesity and metabolic syndrome research
- Pancreatic function investigations
- Appetite regulation mechanisms
- Cardiovascular risk factor analysis

The tirzepatide 10mg peptide features a modified structure with enhanced stability characteristics. Its polyethylene glycol (PEG) modification improves water solubility while maintaining biological activity. Researchers should note this product is intended for laboratory use only, not for human consumption.

Proper storage of tirzepatide 10mg requires maintaining the lyophilized powder at -20°C. When reconstituted, the solution should be used promptly or stored under refrigeration for short-term stability. Always follow appropriate laboratory safety protocols when handling peptide compounds.